Loncar Cancer Immunotherapy ETF | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (37)

View All

Latest Posts

About This Stock More About This Stock
5 Market-Beating Sector ETFs Of Q1
Article By: Sweta Killa
Wednesday, March 27, 2024 2:10 PM EDT
Here are some of the top performers in the ETF space from different sectors of the market.
In this article: KBWP, SMH, CRPT, CNCR, WEED
Read
5 Top-Ranked ETFs To Buy At Bargain Prices For 2023
Article By: Sweta Killa
Wednesday, January 4, 2023 9:46 PM EDT
Here are five ETFs from different zones that have plunged the most over the past year but are poised to outperform when the market resumes its uptrend.
In this article: QCLN, XLY, XRT, CNCR, XWEB
Read
3 Promising Oncology Stocks To Consider Adding To Your Portfolio
Article By: StockNews
Monday, June 14, 2021 12:31 AM EDT
With tech integration and DNA sequencing increasing the efficacy of potential cancer drugs in the pipeline, we believe biotech names AstraZeneca, Amgen and Incyte are worth adding to a portfolio.
In this article: AZN, INCY, AMGN Also: SPY, CNCR
Read
Best Biotech Stocks & ETFs For MRNA, Gene Editing
Podcast By: Neena Mishra
Thursday, April 29, 2021 9:08 PM EDT
2020 was the most challenging year in decades but it was great for scientific innovation, particularly in the biotech space.
In this podcast: PFE, TBIO, IBB, XBI, MRNA, CHNA, CNCR, EDIT, CRSP, BNTX, CVAC
Listen
6 Sector ETFs Surviving The Market Rout
Article By: Sweta Killa
Tuesday, September 15, 2020 3:00 AM EDT
Amid the uncertainties, a few sectors have survived last week’s turmoil. Here are six of that could be compelling picks for the weeks ahead as long as volatility persists.
In this article: ITB, MXI, TAN, RING, CNCR, GERM
Read
All Posts

Latest Tweets for $CNCR

No tweets yet!

PARTNER HEADLINES